GI
ALT icon

GAMMA Investing’s Altimmune ALT Stock Holding History

GAMMA Investing’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.33K Buy
464
+330
+246% +$1.01K ﹤0.01% 4046
2026
Q2 		$407 Buy
+134
New +$400 ﹤0.01% 4015
2025
Q3 		– Sell
-327
Closed -$1.26K – 3850
2025
Q2 		$1.26K Sell
327
-1,022
-76% -$5.53K ﹤0.01% 3492
2025
Q1 		$6.75K Sell
1,349
-798
-37% -$5.05K ﹤0.01% 2941
2024
Q4 		$15.5K Sell
2,147
-220
-9% -$1.68K ﹤0.01% 2395
2024
Q3 		$14.5K Sell
2,367
-852
-26% -$5.77K ﹤0.01% 2286
2024
Q2 		$21.4K Buy
3,219
+3,153
+4,777% +$23.3K ﹤0.01% 1809
2024
Q1 		$672 Buy
+66
New +$671 ﹤0.01% 3036

Other funds holding ALT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return
MWP
Meriwether Wealth & Planning Minden, Louisiana $222M AUM 15.77% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

GAMMA Investing's ALT Position: Q3 2026 in Review

GAMMA Investing increased its Altimmune (ALT) stake by 246% in Q3 2026, buying an estimated $1.01K and bringing the position to 464 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #4046.

GAMMA Investing first reported a position in ALT in Q1 2024 and has held it in 8 quarters since. The position peaked at $21.4K in Q2 2024. 7 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • GAMMA Investing held 464 shares of Altimmune worth $1.33K as of Q3 2026.
  • GAMMA Investing bought 330 Altimmune shares in Q3 2026, an estimated $1.01K.
  • Altimmune made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4046 holding.
  • GAMMA Investing first reported a position in Altimmune in Q1 2024 and has held it in 8 quarters since.
  • GAMMA Investing's Altimmune position peaked at $21.4K in Q2 2024.
  • 7 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.